- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronic acid: multiplicity of use across the cancer continuum
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 11, Issue 7, Pages 1001-1014
Publisher
Informa UK Limited
Online
2011-08-01
DOI
10.1586/era.11.71
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
- (2011) C.L. Shapiro et al. EUROPEAN JOURNAL OF CANCER
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic study
- (2010) Audrey Juillard et al. BONE
- Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment
- (2010) Vittorio Fusco et al. BREAST
- Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
- (2010) Allan Lipton BREAST CANCER RESEARCH AND TREATMENT
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Influence of zoledronic acid on disseminated tumor cells (DTC) in primary breast cancer patients.
- (2010) E Solomayer et al. CANCER RESEARCH
- Bone complications of androgen deprivation therapy: screening, prevention, and treatment
- (2010) Jean-Baptiste Lattouf et al. CURRENT OPINION IN UROLOGY
- Zoledronic acid
- (2010) Robert Coleman et al. Expert Opinion On Drug Safety
- Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
- (2010) Jonathan R. Green et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid
- (2010) I. R. Reid et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells
- (2009) Johanna Räikkönen et al. BIOCHEMICAL PHARMACOLOGY
- Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
- (2009) Adam M. Brufsky et al. Clinical Breast Cancer
- Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies
- (2009) T. Fehm et al. GYNECOLOGIC ONCOLOGY
- Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment
- (2009) Dawn L. Hershman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
- (2009) Konstantinos Vahtsevanos et al. JOURNAL OF CLINICAL ONCOLOGY
- Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone
- (2009) P. D. Ottewell et al. MOLECULAR CANCER THERAPEUTICS
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up
- (2008) I. J. Diel et al. ANNALS OF ONCOLOGY
- Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
- (2008) M. A. Dimopoulos et al. ANNALS OF ONCOLOGY
- Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan
- (2008) C. I. Ripamonti et al. ANNALS OF ONCOLOGY
- Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
- (2008) Allan Lipton et al. CANCER
- Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases
- (2008) Hind T. Hatoum et al. CANCER
- Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo
- (2008) P. D. Ottewell et al. CLINICAL CANCER RESEARCH
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates
- (2008) Ana O Hoff et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Moving Research From Bench to Bedside to Community: There Is Still More to Do
- (2008) Katherine L. Kahn JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer
- (2008) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma
- (2008) Ashraf Badros et al. JOURNAL OF CLINICAL ONCOLOGY
- Structure–Activity Relationships Among the Nitrogen Containing Bisphosphonates in Clinical Use and Other Analogues: Time-Dependent Inhibition of Human Farnesyl Pyrophosphate Synthase
- (2008) James E. Dunford et al. JOURNAL OF MEDICINAL CHEMISTRY
- Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity
- (2008) Vera Hirsh et al. Journal of Thoracic Oncology
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
- Osteonecrosis of the Jaw in Patients with Bone Metastases Treated with Bisphosphonates: A Retrospective Study
- (2008) T. Ibrahim et al. ONCOLOGIST
- Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies
- (2008) Thacharot Boonyapakorn et al. ORAL ONCOLOGY
- Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
- (2008) Luis Costa et al. SUPPORTIVE CARE IN CANCER
- New research findings on zoledronic acid: Survival, pain, and anti-tumour effects
- (2007) Fred Saad CANCER TREATMENT REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now